[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Severe illness after vaccination", "description": "Hospitalisation among vaccine breakthrough COVID-19 infections\n\nhttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00558-2/fulltext\n\nRobust vaccine efficacies at preventing severe symptomatic disease\n\nBreakthrough SARS-CoV-2 infections in fully vaccinated\n\nhttps://covid.joinzoe.com/post/worryingly-close-to-100-000-new-cases-a-day\n\nImpact of vaccination on admission to hospital\n\nPatients with confirmed SARS-CoV-2 infection\n\nYale New Haven Health System, Connecticut\n\nBetween March 23 and July 1, 2021\n\nPatients were considered fully vaccinated 14 days after second dose\n\n969 patients were admitted PCR positive\n\n172 (18%) of 969 patients had received at least one vaccine dose\n\n103 had received a partial vaccine course\n\n15 had received a complete course\n\n54 were fully vaccinated\n\nAmong the 54\n\n25 (46%) patients were asymptomatic\n\n4 (7%) had mild disease\n\n11 (20%) had moderate disease\n\n14 (26%) had severe or critical illness\n\n4 (7%) required ICU\n\n1 required ventilation\n\n3 died\n\nAmong those with severe or critical illness\n\nMedian age 80\u00b75 years\n\nPre-existing comorbidities in the 14 patients with severe or critical illness\n\nBody\u2013mass index more than 25 kg/m\u00b2 (n=9)\n\nCardiovascular disease (n=12)\n\nLung disease (n=7)\n\nMalignancy (n=4)\n\nType 2 diabetes (n=7)\n\nImmunosuppressive agent (n=4)\n\nDifference between vaccines\n\n13 of 14 patients had received BNT162b2, Pfizer\n\n1 of the 14 had received mRNA-1273, Moderna\n\n0 of the 14 had received Ad.26. COV2.S, J and J\n\nMay 17, 2021, vaccine doses in Connecticut\n\nPfizer, 1, 358, 175\n\nModerna, 1, 044, 420\n\nJ and J, 267, 000", "link": "https://www.youtube.com/watch?v=vOyB2PyRf-k", "date_published": "2021-10-31 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]